In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 1114563-58-4, name is 6-Chloro-2,4-dimethylpyridazin-3(2H)-one, introducing its new discovery. Formula: C6H7ClN2O
BET protein inhibitor, preparation method and application thereof (by machine translation)
The invention belongs to the technical field of biological medicines, and particularly relates to BET protein inhibitor, and a preparation method and application. Compared with the prior art, the BET protein inhibitor, based on the existing BET protein inhibitor, is further structurally improved, so that BET protein inhibitor with a new structure is obtained, the BET protein inhibitor has good BET protein inhibition activity and good pharmacokinetic properties, and the BET protein inhibitor is expected to be developed into a new generation high-efficiency and low-toxicity BET protein inhibitor. (by machine translation)
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 1114563-58-4, and how the biochemistry of the body works.Formula: C6H7ClN2O
Reference£º
Pyridazine – Wikipedia,
Pyridazine | C4H4N2082 – PubChem